DSM-Firmenich AG

ENXTAM:DSM Stock Report

Market Cap: €763.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

DSM-Firmenich Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Dimitri de Vreeze

Chief executive officer

€3.3m

Total compensation

CEO salary percentage30.4%
CEO tenure9.7yrs
CEO ownershipn/a
Management average tenure8.3yrs
Board average tenure6yrs

Recent management updates

Need To Know: Koninklijke DSM N.V. (AMS:DSM) Insiders Have Been Selling Shares

Feb 04
Need To Know: Koninklijke DSM N.V. (AMS:DSM) Insiders Have Been Selling Shares

Recent updates

Analyst Forecasts For Koninklijke DSM N.V. (AMS:DSM) Are Surging Higher

May 04
Analyst Forecasts For Koninklijke DSM N.V. (AMS:DSM) Are Surging Higher

Koninklijke DSM (AMS:DSM) Is Reinvesting At Lower Rates Of Return

Mar 27
Koninklijke DSM (AMS:DSM) Is Reinvesting At Lower Rates Of Return

Is Koninklijke DSM (AMS:DSM) A Risky Investment?

Mar 09
Is Koninklijke DSM (AMS:DSM) A Risky Investment?

Here's Why We Think Koninklijke DSM (AMS:DSM) Is Well Worth Watching

Dec 06
Here's Why We Think Koninklijke DSM (AMS:DSM) Is Well Worth Watching

Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?

Nov 18
Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?

Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)

Oct 31
Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)

Why Koninklijke DSM N.V. (AMS:DSM) Could Be Worth Watching

Sep 19
Why Koninklijke DSM N.V. (AMS:DSM) Could Be Worth Watching

Is Now The Time To Put Koninklijke DSM (AMS:DSM) On Your Watchlist?

Aug 23
Is Now The Time To Put Koninklijke DSM (AMS:DSM) On Your Watchlist?

Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?

Aug 08
Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?

Calculating The Intrinsic Value Of Koninklijke DSM N.V. (AMS:DSM)

Jul 23
Calculating The Intrinsic Value Of Koninklijke DSM N.V. (AMS:DSM)

Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70

Apr 30
Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70

Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70

Apr 16
Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70

Koninklijke DSM's (AMS:DSM) Upcoming Dividend Will Be Larger Than Last Year's

Apr 02
Koninklijke DSM's (AMS:DSM) Upcoming Dividend Will Be Larger Than Last Year's

Koninklijke DSM's (AMS:DSM) Dividend Will Be Increased To €1.70

Mar 19
Koninklijke DSM's (AMS:DSM) Dividend Will Be Increased To €1.70

Koninklijke DSM (AMS:DSM) Seems To Use Debt Rather Sparingly

Feb 19
Koninklijke DSM (AMS:DSM) Seems To Use Debt Rather Sparingly

Are Koninklijke DSM N.V. (AMS:DSM) Investors Paying Above The Intrinsic Value?

Nov 23
Are Koninklijke DSM N.V. (AMS:DSM) Investors Paying Above The Intrinsic Value?

We Think Koninklijke DSM (AMS:DSM) Can Stay On Top Of Its Debt

Oct 01
We Think Koninklijke DSM (AMS:DSM) Can Stay On Top Of Its Debt

Does This Valuation Of Koninklijke DSM N.V. (AMS:DSM) Imply Investors Are Overpaying?

Aug 24
Does This Valuation Of Koninklijke DSM N.V. (AMS:DSM) Imply Investors Are Overpaying?

Koninklijke DSM (AMS:DSM) Has A Pretty Healthy Balance Sheet

Jun 29
Koninklijke DSM (AMS:DSM) Has A Pretty Healthy Balance Sheet

Koninklijke DSM N.V.'s (AMS:DSM) Intrinsic Value Is Potentially 17% Below Its Share Price

May 24
Koninklijke DSM N.V.'s (AMS:DSM) Intrinsic Value Is Potentially 17% Below Its Share Price

Is Koninklijke DSM (AMS:DSM) A Risky Investment?

Mar 29
Is Koninklijke DSM (AMS:DSM) A Risky Investment?

Should Koninklijke DSM N.V. (AMS:DSM) Be Part Of Your Dividend Portfolio?

Mar 15
Should Koninklijke DSM N.V. (AMS:DSM) Be Part Of Your Dividend Portfolio?

Are Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Mar 01
Are Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Koninklijke DSM (AMS:DSM) Has Gifted Shareholders With A Fantastic 276% Total Return On Their Investment

Feb 16
Koninklijke DSM (AMS:DSM) Has Gifted Shareholders With A Fantastic 276% Total Return On Their Investment

Need To Know: Koninklijke DSM N.V. (AMS:DSM) Insiders Have Been Selling Shares

Feb 04
Need To Know: Koninklijke DSM N.V. (AMS:DSM) Insiders Have Been Selling Shares

CEO Compensation Analysis

How has Dimitri de Vreeze's remuneration changed compared to DSM-Firmenich's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2022€3m€1m

€454m

Sep 30 2022n/an/a

€837m

Jun 30 2022n/an/a

€1b

Mar 31 2022n/an/a

€1b

Dec 31 2021€3m€994k

€820m

Sep 30 2021n/an/a

€660m

Jun 30 2021n/an/a

€493m

Mar 31 2021n/an/a

€423m

Dec 31 2020€3m€889k

€448m

Sep 30 2020n/an/a

€510m

Jun 30 2020n/an/a

€557m

Mar 31 2020n/an/a

€722m

Dec 31 2019€2m€630k

€675m

Sep 30 2019n/an/a

€820m

Jun 30 2019n/an/a

€794m

Mar 31 2019n/an/a

€934m

Dec 31 2018€2m€614k

€1b

Sep 30 2018n/an/a

€984m

Jun 30 2018n/an/a

€2b

Mar 31 2018n/an/a

€2b

Dec 31 2017€2m€598k

€2b

Sep 30 2017n/an/a

€2b

Jun 30 2017n/an/a

€738m

Mar 31 2017n/an/a

€711m

Dec 31 2016€2m€590k

€645m

Compensation vs Market: Dimitri's total compensation ($USD3.58M) is above average for companies of similar size in the Dutch market ($USD1.20M).

Compensation vs Earnings: Dimitri's compensation has been consistent with company performance over the past year.

CEO

Dimitri de Vreeze (55 yo)

9.7yrs

Tenure

€3,347,000

Compensation

Mr. Dimitri de Vreeze serves as Chief Operating Officer of DSM Nutritional Products AG and has been its Chief Executive Officer and President since April 1, 2021. He serves as President of DSM Resins at DS...

Leadership Team

NamePositionTenureCompensationOwnership
Dimitri de Vreeze
Co-CEO, COO & Member of the Managing Board9.7yrs€3.35mno data
Geraldine Matchett
Co-CEO, CFO & Member of the Managing Board8.8yrs€3.37mno data
Dave Huizing
Vice President of Investor Relations10.8yrsno datano data
Lieke de Jong-Tops
Senior Communications Managerno datano datano data
Cristina Monteiro
Executive Vice President of People & Organization2.7yrsno datano data
Luca Rosetto
Senior Vice President of Operations - Nutritional Productsno datano datano data
Philip Eykerman
President of Food Specialties and Corporate Mergers & Acquisitionsno datano datano data
Patricia Malarkey
Chief Innovation Officer3.8yrsno datano data
Hugh Welsh
General Counsel12.6yrsno datano data
Atul Thakrar
President of Bio-Based Products & Services Unit7.8yrsno datano data
Wilfrid Gambade
President of DSM Dyneemano datano datano data
Patrick Niels
President of Food & Beverage - Royal DSM5.8yrsno datano data

8.3yrs

Average Tenure

55.5yo

Average Age

Experienced Management: DSM's management team is seasoned and experienced (8.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Frits van Paasschen
Independent Member of Supervisory Board6yrs€104.48kno data
Feike Sijbesma
Member of Sustainability Advisory Board & Honorary Chairman3.2yrs€3.35mno data
Robert Routs
Member of Sustainability Advisory Boardno data€53.65kno data
Thomas Leysen
Independent Chairman of Supervisory Board3yrs€129.98k0%
€ 0
John Ramsay
Independent Deputy Chair of Supervisory Board6yrs€104.48k0%
€ 0
Paul Gilding
Member of Sustainability Advisory Boardno datano datano data
David King
Member of Sustainability Advisory Boardno datano datano data
Carla M. Mahieu
Independent Member of the Supervisory Board2yrs€91.43kno data
Eileen Kennedy
Independent Member of Supervisory Board11yrs€109.98kno data
Pradeep Pant
Independent Member of Supervisory Board7.1yrs€102.98kno data
Ye Qi
Member of Sustainability Advisory Boardno datano datano data
Ndidi Nwuneli
Member of Sustainability Advisory Board7.3yrsno datano data

6.0yrs

Average Tenure

64yo

Average Age

Experienced Board: DSM's board of directors are considered experienced (6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/05/31 16:43
End of Day Share Price 2023/05/30 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DSM-Firmenich AG is covered by 61 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mutlu GundoganABN AMRO Bank N.V.
Martin SchneeAlphaValue
Volker BosseBaader Helvea Equity Research